The Trip Report
A podcast by Beckley Waves - Giovedì
Categorie:
38 Episodio
-
Special Dispatch: An Election Retrospective with Nick Gillespie
Pubblicato: 13/11/2024 -
#35 Lucia Huang: Innovative Solutions in Neuropsychiatry
Pubblicato: 31/10/2024 -
#34 Shamil Chandaria: Computational Neuroscience and Human Flourishing
Pubblicato: 17/10/2024 -
#33 Rock Feilding-Mellen: Building the Future of the Psychedelic Field
Pubblicato: 03/10/2024 -
#32 Rachelle Sampson & Bennet Zelner: The Connected Leadership Study
Pubblicato: 19/09/2024 -
Ep #31 Rebecca Kronman: Psychedelics & Parenting
Pubblicato: 05/09/2024 -
Ep #30 Nick Gillespie: Reflection on the FDA’s Rejection of MDMA Assisted Therapy
Pubblicato: 22/08/2024 -
Special Dispatch: FDA Rejects Lykos’ MDMA Assisted Therapy Application
Pubblicato: 13/08/2024 -
#29 Dr. Selma Holden MD: All Eyes on the FDA
Pubblicato: 08/08/2024 -
#28 East Forest: Music for Mushrooms
Pubblicato: 25/07/2024 -
#27 Joanna Kempner: Psychedelic Outlaws
Pubblicato: 11/07/2024 -
#26 Brandon Kapelow: ‘An Act of Service’- A Journey Through PTSD and Ketamine Therapy
Pubblicato: 27/06/2024 -
#25 Christof Koch: Exploring Consciousness and Perception
Pubblicato: 13/06/2024 -
#24 Manesh Girn Ph.D. - Exploring the Psychedelic Brain and Human Potential
Pubblicato: 30/05/2024 -
#23 Dennis Walker: The Court Jester of Psychedelics
Pubblicato: 16/05/2024 -
#22 Bruce Damer: Catalyzing Scientific and Creative Breakthroughs
Pubblicato: 02/05/2024 -
#21: Pedro Teixeira, Ph.D. - Psychedelics and Health Behavior Change
Pubblicato: 18/04/2024 -
#20: Jackie von Salm, Ph.D. - Natural Products & Novel Therapies
Pubblicato: 04/04/2024 -
#19 Beckley Academy: Charting the Course for Psychedelic-Assisted Therapy
Pubblicato: 21/03/2024 -
#18 Rick Doblin: The Path to MDMA Approval and Beyond
Pubblicato: 07/03/2024
The Trip Report is a podcast and newsletter about the business, science, and policy developments of the evolving psychedelic field. While the main organizing theme is psychedelics, it is really about the many different domains that are converging to bring about this field and the assembly of what many believe to be a “New Paradigm” in science, medicine, and our understanding of the human experience. Our goal is to foster an educated and informed psychedelic ecosystem, and to do that, we will feature in-depth conversations with scientists, entrepreneurs, investors and stakeholders at the forefront of the psychedelic renaissance. www.thetripreport.com
